Authors:
Weegink, CJ
Chamuleau, RAFM
Reesink, HW
Molenaar, DSM
Citation: Cj. Weegink et al., Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin, J GASTRO, 36(10), 2001, pp. 723-724
Authors:
Engelfriet, CP
Reesink, HW
Pietersz, RNI
Schwartz, DWM
Mayr, WR
Blajchman, MA
Goldman, M
Decary, F
Sher, G
Georgsen, J
Sprogoe-Jakobsen, U
Kekomaki, R
Kuhnl, P
Seitz, R
Maniatis, A
Pinter, J
Baroti, K
Shinar, E
Rebulla, P
Greppi, N
Sirchia, G
Faber, JC
Flanagan, P
Brand, A
Letowska, M
Nel, T
Argelagues, E
Martin-Vega, C
AuBuchon, JP
Williamson, L
Wallington, T
Citation: Cp. Engelfriet et al., Universal leucocyte-depletion of blood components: cell concentrates and plasma, VOX SANGUIN, 81(1), 2001, pp. 56-77
Authors:
Engelfriet, CP
Reesink, HW
Krusius, T
Wendel, S
Fontao-Wendel, R
Hoffer, I
Medgyesi, G
Tadokoro, K
Pisacka, M
Kuhnl, P
Schwartz, DWM
Mayr, WR
Schonitzer, D
Lin, CK
James, V
Castel, A
Hazenberg, CAM
Letowska, M
Solheim, BG
Guerts, M
Ghosh, S
Flanagan, P
Epstein, J
Safwenberg, J
Riccardi, D
Sirchia, G
Citation: Cp. Engelfriet et al., The use of the computer cross-match, VOX SANGUIN, 80(3), 2001, pp. 184-192
Authors:
van der Meer, PF
Pietersz, RNI
Tiekstra, M
Huijgens, PC
Dekker, WJA
Reesink, HW
Citation: Pf. Van Der Meer et al., WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures, TRANSFUSION, 41(7), 2001, pp. 917-922
Authors:
van der Meer, PF
Pietersz, RNI
Reesink, HW
Citation: Pf. Van Der Meer et al., Influence of temperature, filter wettability, and timing of filtration on the removal of WBCs from RBC concentrates, TRANSFUSION, 41(4), 2001, pp. 540-544
Authors:
Damen, M
Weegink, CJ
Mauser-Bunschoten, EP
Cuypers, HTM
Hermus, MC
Sillekens, P
Haan, E
van den Berg, HM
Bresters, D
Lelie, PN
Chamuleau, RAFM
Reesink, HW
Citation: M. Damen et al., Sustained virological response in chronic hepatitis C patients after a 6-and a 36-month interferon-alpha 2b treatment schedule - A multicenter, randomized, controlled study, SC J GASTR, 36(1), 2001, pp. 97-104
Authors:
Engelfriet, CP
Reesink, HW
de Lange, GG
Flanagan, P
Solheim, BG
Akerblom, O
Messeter, L
James, V
Bruce, M
O'Riordan, J
Murphy, W
Schonitzer, D
Mayr, WR
Henn, G
L'Herminez, P
Kuhnl, P
Kluge, A
Mozzi, F
Rebulla, P
Sirchia, G
Carbonell-Uberos, F
Medgyesi, G
Pisacka, M
Letowska, M
Gustafson, M
Ganz, P
Rees, JW
Decary, F
Wendel, S
Almeida, PTR
Lin, CK
Tadokoro, K
Citation: Cp. Engelfriet et al., Quality assurance, quality control and accreditation, VOX SANGUIN, 79(4), 2000, pp. 253-264
Authors:
Engelfriet, CP
Reesink, HW
Mannucci, PM
Gringeri, A
Ingerslev, J
Brettler, DB
Mauser-Bunschoten, EP
Negrier, C
Berntorp, E
Smith, OP
Shapiro, AD
Citation: Cp. Engelfriet et al., The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies, VOX SANGUIN, 78(4), 2000, pp. 256-261
Citation: Cp. Engelfriet et Hw. Reesink, The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemia, VOX SANGUIN, 78(3), 2000, pp. 200-201
Authors:
Engelfriet, CP
Reesink, HW
Blajchman, MA
Muylle, L
Kjeldsen-Kragh, J
Kekomaki, R
Yomtovian, R
Hocker, P
Stiegler, G
Klein, HG
Soldan, K
Barbara, J
Slopecki, A
Robinson, A
Seyfried, H
Citation: Cp. Engelfriet et al., Bacterial contamination of blood components, VOX SANGUIN, 78(1), 2000, pp. 59-67
Authors:
Beld, M
Habibuw, MR
Rebers, SPH
Boom, R
Reesink, HW
Citation: M. Beld et al., Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems, TRANSFUSION, 40(5), 2000, pp. 575-579
Authors:
Jones, EA
ten Kate, FJW
ter Borg, F
Houben, M
Reesink, HW
Chamuleau, RAFM
Citation: Ea. Jones et al., Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis, EUR J GASTR, 11(10), 1999, pp. 1165-1169
Authors:
Pietersz, RNI
van der Meer, PF
Steneker, I
Hinloopen, B
Dekker, WJA
van Zanten, AP
Reesink, HW
Citation: Rni. Pietersz et al., Preparation of leukodepleted platelet concentrates from pooled buffy coats: Prestorage filtration with Autostop (TM) BC, VOX SANGUIN, 76(4), 1999, pp. 231-236
Citation: Cp. Engelfriet et Hw. Reesink, The treatment of patients with autoimmune thrombocytopenia with intravenous IgG-anti-D, VOX SANGUIN, 76(4), 1999, pp. 250-251
Authors:
van der Meer, PF
Pietersz, RNI
Hinloopen, B
Dekker, WJA
Reesink, HW
Citation: Pf. Van Der Meer et al., Automated separation of whole blood in top and bottom bags into componentsusing the component G4, VOX SANGUIN, 76(2), 1999, pp. 90-99